Format
Sort by
Items per page

Send to

Choose Destination

Best matches for LEVONORGESTREL/TU:

Kyleena--another hormonal IUD. et al. Med Lett Drugs Ther. (2017)

Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective. Siegelmann-Danieli N et al. Breast Cancer Res Treat. (2018)

Liletta--A Third Levonorgestrel-Releasing IUD. et al. Med Lett Drugs Ther. (2015)

Search results

Items: 1 to 20 of 2454

1.

Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.

Wu J, Huang Y, Chen L, Hu J, Zou Y.

Med Sci Monit. 2018 Sep 1;24:6085-6092. doi: 10.12659/MSM.908979.

2.
3.

Long-acting Reversible Contraception-Highly Efficacious, Safe, and Underutilized.

Wu JP, Moniz MH, Ursu AN.

JAMA. 2018 Jul 24;320(4):397-398. doi: 10.1001/jama.2018.8877. Review. No abstract available.

PMID:
29984374
4.

Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.

Lee KH, Jung YW, Song SY, Kang BH, Yang JB, Ko YB, Lee M, Han HY, Yoo HJ.

J Obstet Gynaecol Res. 2018 Sep;44(9):1779-1786. doi: 10.1111/jog.13703. Epub 2018 Jul 5.

PMID:
29974633
5.

[Efficacy and safety of low-dose levonorgestrel-releasing intrauterine system in Chinese women: a multicenter, single-arm, open labeled interventional trial].

Qian CF, Fan GS, Liao QP, Wu SY, La DD, Di W, Dong BH, Liu HW, Tang LD, Xiong ZA, Zhang HW, Hu YL, Yang NM, Ren ML, Shi H, Deng GP, Huang ZR.

Zhonghua Fu Chan Ke Za Zhi. 2018 Jun 25;53(6):409-413. doi: 10.3760/cma.j.issn.0529-567x.2018.06.009. Chinese.

PMID:
29961284
6.

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Thurman AR, Schwartz JL, Brache V, Clark MR, McCormick T, Chandra N, Marzinke MA, Stanczyk FZ, Dezzutti CS, Hillier SL, Herold BC, Fichorova R, Asin SN, Rollenhagen C, Weiner D, Kiser P, Doncel GF.

PLoS One. 2018 Jun 28;13(6):e0199778. doi: 10.1371/journal.pone.0199778. eCollection 2018.

7.

Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding.

van den Brink MJ, Beelen P, Herman MC, Claassen NJJ, Bongers MY, Geomini PM, van der Steeg JW, van den Wijngaard L, van Wely M.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:143-147. doi: 10.1016/j.ejogrb.2018.06.020. Epub 2018 Jun 12.

PMID:
29945042
8.

Pain Perception during Levonorgestrel-releasing Intrauterine Device Insertion in Nulliparous Women: A Systematic Review.

Anthoulakis C, Iordanidou E, Vatopoulou A.

J Pediatr Adolesc Gynecol. 2018 Dec;31(6):549-556.e4. doi: 10.1016/j.jpag.2018.05.008. Epub 2018 Jun 8.

PMID:
29890206
9.

Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study.

Sletten ET, Arnes M, Vereide AB, Ørbo A.

Anticancer Res. 2018 May;38(5):2883-2889.

PMID:
29715112
10.

Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.

Moutchia-Suh J, Mouemba DM, Ngwasiri CA.

J Med Case Rep. 2018 Apr 29;12(1):111. doi: 10.1186/s13256-018-1675-2.

11.

Levonorgestrel-releasing intra-uterine systems as female contraceptives.

Grandi G, Farulla A, Sileo FG, Facchinetti F.

Expert Opin Pharmacother. 2018 May;19(7):677-686. doi: 10.1080/14656566.2018.1462337. Epub 2018 Apr 11. Review.

PMID:
29637798
12.

Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system.

Schreiber CA, Teal SB, Blumenthal PD, Keder LM, Olariu AI, Creinin MD.

Eur J Contracept Reprod Health Care. 2018 Apr;23(2):116-120. doi: 10.1080/13625187.2018.1449825. Epub 2018 Mar 21.

13.

Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa.

Vajapeyam S, Ecklund K, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, Rosen CJ, Gordon CM.

Bone. 2018 May;110:335-342. doi: 10.1016/j.bone.2018.02.021. Epub 2018 Feb 26.

PMID:
29496516
14.

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.

Jareid M, Thalabard JC, Aarflot M, Bøvelstad HM, Lund E, Braaten T.

Gynecol Oncol. 2018 Apr;149(1):127-132. doi: 10.1016/j.ygyno.2018.02.006. Epub 2018 Mar 2.

PMID:
29482839
15.

Postinsertional Pain after Intrauterine Device Placement among Nulliparous Adolescents.

Sinning KM, Jude DC, Yoost JL.

J Pediatr Adolesc Gynecol. 2018 Aug;31(4):400-404. doi: 10.1016/j.jpag.2018.02.127. Epub 2018 Feb 17.

PMID:
29462709
16.

Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.

Lin CJ, Hsu TF, Chang YH, Huang BS, Jiang LY, Wang PH, Chen YJ.

Taiwan J Obstet Gynecol. 2018 Feb;57(1):47-51. doi: 10.1016/j.tjog.2017.12.036.

17.

Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.

Donders GGG, Bellen G, Ruban K, Van Bulck B.

J Med Microbiol. 2018 Mar;67(3):308-313. doi: 10.1099/jmm.0.000657. Epub 2018 Jan 29.

PMID:
29458551
18.

Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy.

Caruso S, Cianci S, Vitale SG, Fava V, Cutello S, Cianci A.

Eur J Contracept Reprod Health Care. 2018 Feb;23(1):24-31. doi: 10.1080/13625187.2018.1433824. Epub 2018 Feb 13.

PMID:
29436865
19.

Cost-effectiveness of emergency contraception options over 1 year.

Bellows BK, Tak CR, Sanders JN, Turok DK, Schwarz EB.

Am J Obstet Gynecol. 2018 May;218(5):508.e1-508.e9. doi: 10.1016/j.ajog.2018.01.025. Epub 2018 Feb 1.

20.

Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique®) in the treatment of endometriosis symptoms: A prospective open-label comparative study.

Scala C, Leone Roberti Maggiore U, Barra F, Venturini PL, Ferrero S.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:89-94. doi: 10.1016/j.ejogrb.2018.01.022. Epub 2018 Feb 3.

PMID:
29408753

Supplemental Content

Loading ...
Support Center